Bonolive®

Bonolive® is a patented olive leaf extract designed to support post-menopausal women and address concerns such as loss of bone mass, joint discomfort, and blood lipids disbalance.

Bonolive® is standardized for highly bioavailable oleuropein (>40%), a powerful phytonutrient unique to the olive tree.

At the cellular level, Bonolive® promotes bone formation by inhibiting adipocyte differentiation and enhancing differentiation into osteoblasts, the bone-building cells.

Additionally, Bonolive® reduces levels of inflammation and cartilage degradation biomarkers, such as PGE-2 and collagen-II, that are involved in the process.

Three clinical studies support bonolive® efficacy. A daily dose of 250 mg of Bonolive® results in the following health benefits:

• Increases bone metabolism biomarker osteocalcin by 32%
• Protects against loss of bone mass density
• Reduces joint pain
• Improves joints mobility
• Improves blood lipid profile

Bonolive® is water-soluble and has shown excellent bioavailability in humans. It can be formulated in various dietary supplement forms, including capsules, sachets, tablets, chewable, gummies, shots and shelf-stable drinks.

Key applications:

• Post-menopausal women's health
• Osteopenia, osteoporosis, and bone health support
• Osteoarthritis and joint health